1. Home
  2. NVCT vs TEAF Comparison

NVCT vs TEAF Comparison

Compare NVCT & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • TEAF
  • Stock Information
  • Founded
  • NVCT 2020
  • TEAF 2017
  • Country
  • NVCT United States
  • TEAF United States
  • Employees
  • NVCT N/A
  • TEAF N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • TEAF Trusts Except Educational Religious and Charitable
  • Sector
  • NVCT Health Care
  • TEAF Finance
  • Exchange
  • NVCT Nasdaq
  • TEAF Nasdaq
  • Market Cap
  • NVCT 152.3M
  • TEAF 161.5M
  • IPO Year
  • NVCT 2022
  • TEAF N/A
  • Fundamental
  • Price
  • NVCT $6.43
  • TEAF $12.09
  • Analyst Decision
  • NVCT Strong Buy
  • TEAF
  • Analyst Count
  • NVCT 3
  • TEAF 0
  • Target Price
  • NVCT $15.33
  • TEAF N/A
  • AVG Volume (30 Days)
  • NVCT 234.7K
  • TEAF 56.1K
  • Earning Date
  • NVCT 08-05-2025
  • TEAF 01-01-0001
  • Dividend Yield
  • NVCT N/A
  • TEAF 9.20%
  • EPS Growth
  • NVCT N/A
  • TEAF N/A
  • EPS
  • NVCT N/A
  • TEAF N/A
  • Revenue
  • NVCT N/A
  • TEAF N/A
  • Revenue This Year
  • NVCT N/A
  • TEAF N/A
  • Revenue Next Year
  • NVCT N/A
  • TEAF N/A
  • P/E Ratio
  • NVCT N/A
  • TEAF N/A
  • Revenue Growth
  • NVCT N/A
  • TEAF N/A
  • 52 Week Low
  • NVCT $4.44
  • TEAF $11.11
  • 52 Week High
  • NVCT $11.80
  • TEAF $13.30
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 39.18
  • TEAF 52.27
  • Support Level
  • NVCT $6.18
  • TEAF $12.00
  • Resistance Level
  • NVCT $6.99
  • TEAF $12.12
  • Average True Range (ATR)
  • NVCT 0.50
  • TEAF 0.11
  • MACD
  • NVCT -0.03
  • TEAF -0.01
  • Stochastic Oscillator
  • NVCT 31.18
  • TEAF 46.33

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About TEAF Ecofin Sustainable and Social Impact Term Fund

Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.

Share on Social Networks: